Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

3 months ago

Nottingham, U.K.-based dose form development and clinical manufacturing specialist, Juniper will add a European Early Development Center of Excellence to Catalent’s global network. When combined with Catalent’s existing centers of excellence for early drug development in the U.S. and Europe, the acquisition of Juniper will expand and strengthen Catalent’s offerings and will complement its integrated